Corrigendum: Validation of the neuroconnective endophenotype questionnaire (NEQ): a new clinical tool for medicine and psychiatry resulting from the contribution of Ehlers-Danlos syndrome

Front Med (Lausanne). 2023 Dec 7:10:1338616. doi: 10.3389/fmed.2023.1338616. eCollection 2023.

Antonio Bulbena^{1

2}, Silvia Rosado^{2

3}, Marina Cabaleiro^{1

2}, María Martinez^{1

2}, Carolina Baeza-Velasco^{4

5

6}, Luis-Miguel Martin², Santiago Batlle², Andrea Bulbena-Cabré⁷

¹ Department of Psychiatry and Forensic Medicine, Universitat Autonoma Barcelona, Barcelona, Spain.
² Anxiety Unit, Hospital del Mar, Institute Neuropsychiatry and Addictions (INAD) CIBERSAM, Barcelona, Spain.
³ Doctorate Program in Psychiatry, Department of Psychiatry and Forensic Medicine, Universitat Autonoma Barcelona, Barcelona, Spain.
⁴ Laboratoire de Psychopathologie et Processus de Santé, Université Paris Cité, Paris, France.
⁵ Department of Emergency Psychiatry and Acute Care, CHU Montpellier, Montpellier, France.
⁶ Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France.
⁷ Icahn School of Medicine, Mount Sinai, New York, NY, United States.

Abstract

[This corrects the article DOI: 10.3389/fmed.2023.1039223.].

Keywords: Ehlers-Danlos syndrome; anxiety; joint hypermobility; neuroconnective endophenotype; psychosomatic medicine; reliability; validity.